Recordati Industria Chimica E Farmaceutica S.P.A. (RCDTF)
(Delayed Data from OTC)
$51.60 USD
0.00 (0.00%)
Updated Jan 25, 2024 10:25 AM ET
2-Buy of 5 2
B Value C Growth NA Momentum NA VGM
Income Statements
Fiscal Year end for Recordati Industria Chimica E Farmaceutica SPA falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | NA | 1,953 | 1,869 | 1,655 | 1,660 |
Cost Of Goods | NA | 597 | 506 | 465 | 489 |
Gross Profit | NA | 1,356 | 1,363 | 1,190 | 1,170 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 895 | 783 | 655 | 649 |
Income After Depreciation & Amortization | 0 | 461 | 580 | 536 | 521 |
Non-Operating Income | NA | 0 | 0 | 0 | 0 |
Interest Expense | NA | 38 | 32 | 15 | 24 |
Pretax Income | NA | 423 | 548 | 521 | 497 |
Income Taxes | NA | 94 | 92 | 115 | 84 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | 329 | 457 | 406 | 413 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | 329 | 457 | 406 | 413 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 593 | 695 | 643 | 609 |
Depreciation & Amortization (Cash Flow) | NA | 133 | 115 | 107 | 88 |
Income After Depreciation & Amortization | 0 | 461 | 580 | 536 | 521 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | NA | 205.62 | 206.01 | 205.79 | 209.08 |
Diluted EPS Before Non-Recurring Items | NA | 2.39 | 2.44 | 2.25 | 1.98 |
Diluted Net EPS (GAAP) | NA | 1.57 | 2.18 | 1.94 | 1.98 |
Fiscal Year end for Recordati Industria Chimica E Farmaceutica SPA falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | NA | 557.14 | 536.58 | 591.83 |
Cost Of Goods | NA | NA | NA | NA | 175.67 |
Gross Profit | NA | NA | NA | NA | 416.17 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 230.94 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 185.23 |
Non-Operating Income | NA | NA | NA | NA | 0.00 |
Interest Expense | NA | NA | NA | NA | 13.55 |
Pretax Income | NA | NA | NA | NA | 171.68 |
Income Taxes | NA | NA | NA | NA | 38.63 |
Minority Interest | NA | NA | NA | NA | 0.00 |
Investment Gains/Losses | NA | NA | NA | NA | 0.00 |
Other Income/Charges | NA | NA | NA | NA | 0.00 |
Income From Cont. Operations | NA | NA | 83.72 | 112.80 | 133.05 |
Extras & Discontinued Operations | NA | NA | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | NA | 83.72 | 112.80 | 133.05 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | 206.22 | 205.18 | 205.56 |
Diluted EPS Before Non-Recurring Items | NA | NA | 0.62 | 0.69 | 0.81 |
Diluted Net EPS (GAAP) | NA | NA | 0.40 | 0.54 | 0.64 |